[Use of labeled lipids for the determination of steatorrhea in patients with chronic liver disease].
作者信息
Bondar S A, Feklissowa M E, Beloussowa N D
出版信息
Dtsch Z Verdau Stoffwechselkr. 1965 Oct;25(4):248-50.
PMID:5888912
Abstract
摘要
相似文献
1
[Use of labeled lipids for the determination of steatorrhea in patients with chronic liver disease].[使用标记脂质测定慢性肝病患者的脂肪泻]
Dtsch Z Verdau Stoffwechselkr. 1965 Oct;25(4):248-50.
2
Rapid diagnosis of steatorrhea by external counting of abdomen after iodine-131-labeled fat administration.
J Nucl Med. 1966 Dec;7(12):896-908.
3
[Nutrition disorders in liver diseases].[肝脏疾病中的营养紊乱]
Z Gesamte Inn Med. 1971 Mar 15;26(6):Suppl:59-61.
4
5
[Steatorrhea caused by blocking of the afferent lymphatic circulation during malignant disease of the deep lymphatic lymph nodes].[深部淋巴结恶性疾病时传入淋巴循环受阻所致的脂肪泻]
Presse Med (1893). 1968 Sep 7;76(32):1601-2.
6
Studies on idiopathic steatorrhea with fat labeled (I-131).用标记脂肪（碘-131）对特发性脂肪泻的研究。
Gastroenterologia. 1960;93:228-35. doi: 10.1159/000202830.
7
[Pathogenesis of steatorrhea in chronic diseases of the small intestine].[小肠慢性疾病中脂肪泻的发病机制]
Ter Arkh. 1984;56(11):55-8.
8
[Diagnosis of chronic pancreatitis and chronic pancreatopathy using labeled lipids].[使用标记脂质诊断慢性胰腺炎和慢性胰腺病]
Vrach Delo. 1969 Mar;3:27-30.
9
[Significance of fat absorption tests using 131-I-labeled lipids].
Med Klin. 1971 Mar 19;66(12):431-9.
10
Steatorrhea and weight loss in a 72-year-old man: primary biliary cirrhosis? Celiac disease? Bacterial overgrowth? What else?
Am J Gastroenterol. 1998 Nov;93(11):2226-30. doi: 10.1111/j.1572-0241.1998.00620.x.
Zotero 插件